4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001470831-25-000223
Chief Financial Officer gave up 2,775 shares (to pay taxes)
- Chief Financial Officer acquired 6,250 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Adams Kendra · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-09-18 | Exercise or conversion : show line 1 in the form | +6,250 | 165,117 | D | ||
| 2025-09-18 | Shares withheld for taxes : show line 2 in the form | −2,775 | $3.32 | $9,213 | 162,342 | D |
Loading xslF345X05/wk-form4_1758312827.xml…